Ruishu Mou

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University

发表论文 12 篇 · 总被引 121 次 · h-index 4

代表论文

• A Copper/Ferrous‐Engineering Redox Homeostasis Disruptor for Cuproptosis/Ferroptosis Co‐Activated Nanocatalytic Therapy in Liver Cancer (2024 · Advanced Functional Materials · 被引 88)
• Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma (2023 · BMC Cancer · 被引 13)
• RETRACTED: Streptococcus anginosus promotes gastric cancer progression via GSDME-mediated pyroptosis pathway: Molecular mechanisms of action of GSDME, cleaved caspase-3, and NLRP3 proteins (2025 · International Journal of Biological Macromolecules · 被引 7)
• Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy (2024 · Cancer Medicine · 被引 7)
• Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing (2023 · Functional & Integrative Genomics · 被引 4)
• A Self‐Reinforcing Photonanocatalytic Platform Remodels Tumor Microenvironment for Synergistic Apoptosis/Ferroptosis Therapy in Liver Cancer (2026 · Advanced Functional Materials · 被引 1)